ScholarIQanswers from OpenAlex & ORCID
Kenneth B. Margulies
ResearcherPublications, citations & collaboration network
Kenneth B. Margulies is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kenneth B. Margulies have?
ScholarIQindexed works
Kenneth B. Margulies has 607 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kenneth B. Margulies have?
ScholarIQcitation count
Kenneth B. Margulies has 28,806 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kenneth B. Margulies?
ScholarIQh-index
Kenneth B. Margulies has an h-index of 89 in OpenAlex.
What is the i10-index of Kenneth B. Margulies?
ScholarIQi10-index
Kenneth B. Margulies has an i10-index of 275 in OpenAlex.
What is the ORCID of Kenneth B. Margulies?
ScholarIQorcid
The ORCID for Kenneth B. Margulies is on the source record.
What is the OpenAlex record for Kenneth B. Margulies?
ScholarIQopenalex
The OpenAlex for Kenneth B. Margulies is on the source record.
What are the most-cited papers on Kenneth B. Margulies?
ScholarIQmost cited works
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
Sonia Shah, Albert Henry, Carolina Roselli, Honghuang Lin, Garðar Sveinbjörnsson, Ghazaleh Fatemifar, Åsa K. Hedman, Jemma B. Wilk, Michael P. Morley, Mark Chaffin, Anna Helgadóttir, Niek Verweij, Abbas Dehghan, Peter Almgren, Charlotte Andersson, Krishna G. Aragam, Johan Ärnlöv, Joshua Backman, Mary L. Biggs, Heather L. Bloom, Jeffrey Brandimarto, Michael R. Brown, Leonard Buckbinder, David J. Carey, Daniel I. Chasman, Xing Chen, Xu Chen, Jonathan Chung, William A. Chutkow, James P. Cook, Graciela E. Delgado, Spiros Denaxas, Alex S. F. Doney, Marcus Dörr, Samuel C. Dudley, Michael E. Dunn, Gunnar Engström, Tõnu Esko, Stephan B. Felix, Chris Finan, Ian Ford, Mohsen Ghanbari, Sahar Ghasemi, Vilmantas Giedraitis, Franco Giulianini, John S. Gottdiener, Stefan Groß, Daníel F. Guðbjartsson, Rebecca Gutmann, Christopher M. Haggerty, Pim van der Harst, Craig Hyde, Erik Ingelsson, J. Wouter Jukema, Maryam Kavousi, Kay‐Tee Khaw, Marcus E. Kleber, Lars Køber, Andrea Koekemoer, Claudia Langenberg, Lars Lind, Cecilia M. Lindgren, Barry London, Luca A. Lotta, Ruth C. Lovering, Jian’an Luan, Patrik K. E. Magnusson, Anubha Mahajan, Kenneth B. Margulies, Winfried März, Olle Melander, Ify Mordi, Thomas M. Morgan, Andrew D. Morris, Andrew P. Morris, Alanna C. Morrison, Michael W. Nagle, Christopher P. Nelson, Alexander Niessner, Teemu Niiranen, Michelle L. O’Donoghue, Anjali Owens, Colin N. A. Palmer, Helen Parry, Markus Perola, Eliana Portilla-Fernández, Bruce M. Psaty, Goncalo Abecasis, Joshua Backman, Xiaodong Bai, Suganthi Balasubramanian, Nilanjana Banerjee, Aris Baras, Leland Barnard, Christina Beechert, Andrew Blumenfeld, Michael Cantor, Yating Chai, Jonathan Chung, Giovanni Coppola
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
Kenneth B. Margulies, Adrian F. Hernandez, Margaret M. Redfield, Michael M. Givertz, Guilherme H. Oliveira, Robert T. Cole, Douglas L. Mann, David J. Whellan, Michael S. Kiernan, G. Michael Felker, Steven E. McNulty, Kevin J. Anstrom, Monica Shah, Eugene Braunwald, Thomas P. Cappola
Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure
Kenneth Bedi, Nathaniel W. Snyder, Jeffrey Brandimarto, Moez Karim Aziz, Clementina Mesaros, Andrew J. Worth, Linda L. Wang, Ali Javaheri, Ian A. Blair, Kenneth B. Margulies, J. Eduardo Rame
Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction
Horng H. Chen, Kevin J. Anstrom, Michael M. Givertz, Lynne W. Stevenson, Marc J. Semigran, Steven R. Goldsmith, Bradley A. Bart, David A. Bull, Josef Stehlik, Martin M. LeWinter, Marvin A. Konstam, Gordon S. Huggins, Jean L. Rouleau, Eileen O’Meara, W.H. Wilson Tang, Randall C. Starling, Javed Butler, Anita Deswal, G. Michael Felker, Christopher M. O’Connor, Raphael Bonita, Kenneth B. Margulies, Thomas P. Cappola, Elizabeth Ofili, Douglas L. Mann, Víctor G. Dávila‐Román, Steven E. McNulty, Barry A. Borlaug, Eric J. Velazquez, Kerry L. Lee, Monica Shah, Adrian F. Hernandez, Eugene Braunwald, Margaret M. Redfield
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction
Michael E. Nassif, Sheryl L. Windsor, Fengming Tang, Yevgeniy Khariton, Mansoor Husain, Silvio E. Inzucchi, Darren K. McGuire, Bertram Pitt, Benjamin M. Scirica, Bethany A. Austin, Mark H. Drazner, Michael Fong, Michael M. Givertz, Robert Gordon, Rita Jermyn, Stuart D. Katz, Sumant Lamba, David E. Lanfear, Shane LaRue, JoAnn Lindenfeld, Michael Malone, Kenneth B. Margulies, Robert J. Mentz, R. Kannan Mutharasan, Michael Pursley, Guillermo E. Umpierrez, Mikhail Kosiborod, On behalf of the DEFINE-HF Investigators, Ali O. Malik, Nannette Wenger, Modele O. Ogunniyi, Priyathama Vellanki, Brenda Murphy, Jonathan Newman, Justin Hartupee, Charu Gupta, Marcela Goldsmith, Paramdeep Baweja, Manuel Montero, Stephen S. Gottlieb, Maria Rosa Costanzo, Thanh T. Hoang, Alicia Warnock, Larry A. Allen, W.H. Wilson Tang, Horng H. Chen, John M. Cox